Sequencing platform of Strasbourg GENOMAX
GENOMAX applies various next-generation sequencing (NGS) methods and develops NGS-based tools in the context of scientific collaborations and services. Composed of a multidisciplinary team of engineers, technicians, bioinformaticians and biostatisticians, the platform is mainly dedicated to the implementation of genomic and transcriptomic sequencing projects using Illumina and Ion Torrent techniques. It offers personalised support, from the experimental design to the interpretation of the data.
Expertise
- Preparation of sequencing libraries for Ion Torrent and Illumina
- Targeted DNA sequencing: amplicons, custom panels, exomes
- RNA sequencing: tRNA, mRNA and small RNAs
- Sanger sequencing
- Sequencing of user prepared libraries
- Single cell transcript sequencing (scRNA-Seq)
- Bioinformatics and biostatistical analysis of the data produced
- Development of bioinformatics tools and analysis pipelines
- Development of exome, genome, RNA-Seq and scRNA-Seq pipelines
Equipments
- Library preparation: STARlet NGS machine (Hamilton), BioAnalyzer 2100 (Agilent), Qubit, Covaris S220, Nanodro
- Sanger sequencing: ABI 3130XL 16 capillaries and ABI 3730XL 96 capillaries (Thermo Fisher Scientific)
- High-throughput sequencing: NextSeq 500 and NextSeq 2000 (Illumina), Ion S5 and Ion Proton (Thermo Fisher Scientific)
- Single cell sequencing: Chromium Connect and Chromium Controller (10X Genomics)
- IT infrastructure: 2 servers with 48 cores and storage > 80 Tb
Main achievements
Genomax carries out about 50 sequencing projects per year. Members of the platform are co-authors of more than 50 publications (see: https://pubmed.ncbi.nlm.nih.gov/?term=genomax+strasbourg&sort=date&size=100 )
The platform is particularly involved in the genetic exploration of immune-mediated diseases, including autoimmune diseases, immune deficiencies and transplantation-related complications. It is also interested in the identification of genes responsible for various diseases through familial exome analysis.
Examples of publications:
- Carapito, R., R. Li, J. Helms, C. Carapito, S. Gujja, V. Rolli, R. Guimaraes, J. Malagon-Lopez, P. Spinnhirny, A. Lederle, R. Mohseninia, A. Hirschler, L. Muller, P. Bastard, A. Gervais, Q. Zhang, F. Danion, Y. Ruch, M. Schenck, O. Collange, T. N. Chamaraux-Tran, A. Molitor, A. Pichot, A. Bernard, O. Tahar, S. Bibi-Triki, H. Wu, N. Paul, S. Mayeur, A. Larnicol, G. Laumond, J. Frappier, S. Schmidt, A. Hanauer, C. Macquin, T. Stemmelen, M. Simons, X. Mariette, O. Hermine, S. Fafi-Kremer, B. Goichot, B. Drenou, K. Kuteifan, J. Pottecher, P. M. Mertes, S. Kailasan, M. J. Aman, E. Pin, P. Nilsson, A. Thomas, A. Viari, D. Sanlaville, F. Schneider, J. Sibilia, P. L. Tharaux, J. L. Casanova, Y. Hansmann, D. Lidar, M. Radosavljevic, J. R. Gulcher, F. Meziani, C. Moog, T. W. Chittenden and S. Bahram (2022). “Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort.” Sci Transl Med 14(628): eabj7521.
- Castro, C. N., M. Rosenzwajg, R. Carapito, M. Shahrooei, M. Konantz, A. Khan, Z. Miao, M. Gross, T. Tranchant, M. Radosavljevic, N. Paul, T. Stemmelen, F. Pitoiset, A. Hirschler, B. Nespola, A. Molitor, V. Rolli, A. Pichot, L. E. Faletti, B. Rinaldi, S. Friant, M. Mednikov, H. Karauzum, M. J. Aman, C. Carapito, C. Lengerke, V. Ziaee, W. Eyaid, S. Ehl, F. Alroqi, N. Parvaneh and S. Bahram (2020). “NCKAP1L defects lead to a novel syndrome combining immunodeficiency, lymphoproliferation, and hyperinflammation.” J Exp Med 217(12).
- Carapito, R., E. L. Ivanova, A. Morlon, L. Meng, A. Molitor, E. Erdmann, B. Kieffer, A. Pichot, L. Naegely, A. Kolmer, N. Paul, A. Hanauer, F. Tran Mau-Them, N. Jean-Marcais, S. M. Hiatt, G. M. Cooper, T. Tvrdik, A. M. Muir, C. Dimartino, M. Chopra, J. Amiel, C. T. Gordon, F. Dutreux, A. Garde, C. Thauvin-Robinet, X. Wang, M. S. Leduc, M. Phillips, H. P. Crawford, M. K. Kukolich, D. Hunt, V. Harrison, M. Kharbanda, S. Deciphering Developmental Disorders, G. University of Washington Center for Mendelian, R. Smigiel, N. Gold, C. Y. Hung, D. H. Viskochil, S. L. Dugan, P. Bayrak-Toydemir, G. Joly-Helas, A. M. Guerrot, C. Schluth-Bolard, M. Rio, I. M. Wentzensen, K. McWalter, R. E. Schnur, A. M. Lewis, S. R. Lalani, N. Mensah-Bonsu, J. Ceraline, Z. Sun, R. Ploski, C. A. Bacino, H. C. Mefford, L. Faivre, O. Bodamer, J. Chelly, B. Isidor and S. Bahram (2019). “ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder.” Am J Hum Genet 104(2): 319-330.
- Molitor, A., T. Prud’homme, Z. Miao, S. Conrad, A. Bloch-Zupan, A. Pichot, A. Hanauer, B. Isidor, S. Bahram and R. Carapito (2019). “Exome sequencing identifies a novel missense variant in CTSC causing nonsyndromic aggressive periodontitis.” J Hum Genet 64(7): 689-694.
- Carapito, R., C. Carapito, A. Morlon, N. Paul, A. S. Vaca Jacome, G. Alsaleh, V. Rolli, O. Tahar, I. Aouadi, M. Rompais, F. Delalande, A. Pichot, P. Georgel, L. Messer, J. Sibilia, S. Cianferani, A. Van Dorsselaer and S. Bahram (2018). “Multi-OMICS analyses unveil STAT1 as a potential modifier gene in mevalonate kinase deficiency.” Ann Rheum Dis 77(11): 1675-1687.
- Domingo-Calap, P., B. Schubert, M. Joly, M. Solis, M. Untrau, R. Carapito, P. Georgel, S. Caillard, S. Fafi-Kremer, N. Paul, O. Kohlbacher, F. Gonzalez-Candelas and S. Bahram (2018). “An unusually high substitution rate in transplant-associated BK polyomavirus in vivo is further concentrated in HLA-C-bound viral peptides.” PLoS Pathog 14(10): e1007368.
- Carapito, R., M. Konantz, C. Paillard, Z. Miao, A. Pichot, M. S. Leduc, Y. Yang, K. L. Bergstrom, D. H. Mahoney, D. L. Shardy, G. Alsaleh, L. Naegely, A. Kolmer, N. Paul, A. Hanauer, V. Rolli, J. S. Muller, E. Alghisi, L. Sauteur, C. Macquin, A. Morlon, C. S. Sancho, P. Amati-Bonneau, V. Procaccio, A. L. Mosca-Boidron, N. Marle, N. Osmani, O. Lefebvre, J. G. Goetz, S. Unal, N. A. Akarsu, M. Radosavljevic, M. P. Chenard, F. Rialland, A. Grain, M. C. Bene, M. Eveillard, M. Vincent, J. Guy, L. Faivre, C. Thauvin-Robinet, J. Thevenon, K. Myers, M. D. Fleming, A. Shimamura, E. Bottollier-Lemallaz, E. Westhof, C. Lengerke, B. Isidor and S. Bahram (2017). “Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features.” J Clin Invest 127(11): 4090-4103.
- Carapito, R., A. Goldenberg, N. Paul, A. Pichot, A. David, A. Hamel, C. Dumant-Forest, J. Leroux, B. Ory, B. Isidor and S. Bahram (2016). “Protein-altering MYH3 variants are associated with a spectrum of phenotypes extending to spondylocarpotarsal synostosis syndrome.” Eur J Hum Genet 24(12): 1746-1751.
- Carapito, R., B. Isidor, N. Guerouaz, M. Untrau, M. Radosavljevic, E. Launay, E. Cassagnau, C. Frenard, H. Aubert, B. Romefort, C. Le Caignec, L. Ott, N. Paul, S. Barbarot and S. Bahram (2015). “Homozygous IL36RN mutation and NSD1 duplication in a patient with severe pustular psoriasis and symptoms unrelated to deficiency of interleukin-36 receptor antagonist.” Br J Dermatol 172(1): 302-305.
- Carapito, R., N. Paul, M. Untrau, M. Le Gentil, L. Ott, G. Alsaleh, P. Jochem, M. Radosavljevic, C. Le Caignec, A. David, P. Damier, B. Isidor and S. Bahram (2015). “A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia.” Mov Disord 30(3): 423-427.
Last update February 2022
Certification / Quality Assurance
Labels
IBISA
Ion Torrent Certified Service Provider (Exome)
Platform Managment
Raphaël Carapito (Scientific manager)
Anne Molitor (Technical manager)
Plateforme Genomax
UMR_S 1109 – IRM / Immunorhumatologie moléculaire
INSERM, UNIVERSITE DE STRASBOURG
1, place de l’Hôpital
67000 Strasbourg